Regeneron is a biopharmaceutical company that researches, develops, and commercializes medicines for people with serious diseases. Utilizing proprietary technologies in antibodies and genetic medicines, the company serves patients globally by addressing conditions in areas such as oncology, immunology, ophthalmology, and rare diseases.
Subscribe to see Regeneron’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Regeneron is a biotech company headquartered in United States. Xcout tracks 18 named people at Regeneron, including Leonard S. Schleifer (Board co-Chair, President and Chief Executive Officer). Xcout recorded 2 job postings from Regeneron in the last 90 days.
12 more named people on record for Regeneron, with roles, board committees and tenure — see the full roster →
Xcout recorded 2 job postings from Regeneron in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Regeneron's hiring signals →
A few of Regeneron's closest competitors — see the full list of competitors and alternatives →
Samsung Bioepis is a South Korean biopharmaceutical company that develops and commercializes biosimilar medicines, including products in immunology, oncology, ophthalmology, and hematology. Its medicines are supplied to healthcare systems and patients in international markets through partnerships and commercialization agreements.
Johnson & Johnson develops and delivers medical treatments and technologies across multiple healthcare sectors, including innovative medicines for oncology, immunology, neuroscience, and cardiopulmonary conditions. The company also provides medical devices and technologies focused on cardiovascular, orthopaedics, surgery, and vision care for patients globally.
Amgen Inc. is an American multinational biopharmaceutical and biotechnology company headquartered in Thousand Oaks, California. The company focuses on discovering, developing, manufacturing, and delivering innovative medicines to address severe diseases.
AstraZeneca is an innovative biopharmaceutical company that researches, develops, and manufactures modern medicines for patients. It addresses major medical challenges across therapeutic areas such as oncology, cardiovascular and metabolic diseases, respiratory conditions, and immunology.
Decibel Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, which agreed to merge with Regeneron Pharmaceuticals.
AbCellera is a biotechnology company that integrates biology, computation, and engineering to discover and develop antibody-based medicines. The company operates a proprietary technology platform to advance internal and partnered drug programs across therapeutic areas such as endocrinology, immunology, autoimmunity, and oncology.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Regeneron? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.